Loading ...GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced data with the EndoBarrier Gastrointestinal Liner at 12 months showing significant weight loss and cardiovascular and metabolic improvements in obese patients.
Popular
type 2 diabetes type 1 diabetes Diabetes Complications diabetes research diabetes management managing diabetes JDRF diabetes support american diabetes association Diabetes Community women's health obesity type 2 diabetes risk children's health type 2 diabetes prevention kids with diabetes diabetes type 2 diabetes treatment insulin diabetes treatment obesity epidemic insulin resistance juvenile diabetes children with diabetes Tanya Zuckerbrot